These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 39167332)

  • 1. Patient Preferences for Attributes of Androgen Deprivation Therapies in Prostate Cancer: A Discrete Choice Experiment with Latent Class Analysis.
    Hauber B; Hong A; Hunsche E; Maculaitis MC; Collins SP
    Adv Ther; 2024 Oct; 41(10):3934-3950. PubMed ID: 39167332
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patient preference on once-daily oral versus injectable androgen deprivation therapy for Asian patients with advanced prostate cancer.
    Wong HC; Cheung BC; Yuen VW; Teoh JY; Chiu PK; Ng CF
    Int Urol Nephrol; 2024 Sep; 56(9):2923-2928. PubMed ID: 38512441
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Public Preference Heterogeneity and Predicted Uptake Rate of Upper Gastrointestinal Cancer Screening Programs in Rural China: Discrete Choice Experiments and Latent Class Analysis.
    Liu R; Li Q; Li Y; Wei W; Ma S; Wang J; Zhang N
    JMIR Public Health Surveill; 2023 Jul; 9():e42898. PubMed ID: 37428530
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patient Preferences for Preventive Migraine Treatments: A Discrete-Choice Experiment.
    Mansfield C; Gebben DJ; Sutphin J; Tepper SJ; Schwedt TJ; Sapra S; Shah N
    Headache; 2019 May; 59(5):715-726. PubMed ID: 30861110
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preferences heterogeneity of health care utilization of community residents in China: a stated preference discrete choice experiment.
    Jiang MZ; Fu Q; Xiong JY; Li XL; Jia EP; Peng YY; Shen X
    BMC Health Serv Res; 2020 May; 20(1):430. PubMed ID: 32423447
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patient preferences do matter: a discrete choice experiment conducted with breast cancer patients in six European countries, with latent class analysis.
    Stamuli E; Corry S; Foss P
    Int J Technol Assess Health Care; 2023 Apr; 39(1):e21. PubMed ID: 37074007
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Information needs of men on androgen deprivation therapy.
    Soeyonggo T; Warde P; Fleshner N; Timilshina N; Alibhai SM
    BJU Int; 2012 May; 109(10):1503-9. PubMed ID: 21883845
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preferences for herpes zoster vaccination among adults aged 50 years and older in the United States: results from a discrete choice experiment.
    Patterson BJ; Myers K; Stewart A; Mange B; Hillson EM; Poulos C
    Expert Rev Vaccines; 2021 Jun; 20(6):729-741. PubMed ID: 33902368
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patient Preferences for Metastatic Hormone-Sensitive Prostate Cancer Treatments: A Discrete Choice Experiment Among Men in Three European Countries.
    de Freitas HM; Ito T; Hadi M; Al-Jassar G; Henry-Szatkowski M; Nafees B; Lloyd AJ
    Adv Ther; 2019 Feb; 36(2):318-332. PubMed ID: 30617763
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Variation in Preferences for Long-Acting Injectable Pre-Exposure Prophylaxis Among US Men Who Have Sex with Men: A Latent Class Analysis.
    Beckham SW; Sanchez T; Fowler R; Zlotorzynska M; Rai M; Sullivan P; Vannappagari V; Sarkar S; Glick JL; Rinehart AR; Rawlings K; Bridges JFP
    AIDS Patient Care STDS; 2023 Oct; 37(10):495-503. PubMed ID: 37862078
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chinese patients' preference for pharmaceutical treatments of osteoporosis: a discrete choice experiment.
    Si L; Tu L; Xie Y; Palmer AJ; Gu Y; Zheng X; Li J; Lv Q; Qi J; Lin Z; Chen M; Gu J; Hiligsmann M
    Arch Osteoporos; 2019 Jul; 14(1):85. PubMed ID: 31367860
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Public Preference for Off-Label Use of Drugs for Cancer Treatment and Relative Importance of Associated Adverse Events: A Discrete Choice Experiment and Best-Worst Scaling.
    Wang K; Shum HM; Yam CH; Wu Y; Wong EL; Yeoh EK
    Appl Health Econ Health Policy; 2024 Nov; 22(6):849-860. PubMed ID: 39256322
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Testosterone Recovery Profiles After Cessation of Androgen Deprivation Therapy for Prostate Cancer.
    Nascimento B; Miranda EP; Jenkins LC; Benfante N; Schofield EA; Mulhall JP
    J Sex Med; 2019 Jun; 16(6):872-879. PubMed ID: 31080102
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preferred treatment frequency in patients receiving androgen deprivation therapy for advanced prostate cancer.
    Fode M; Nielsen TK; Al-Hamadani M; Andersen JR; Jakobsen H; Sønksen J
    Scand J Urol; 2014 Apr; 48(2):183-8. PubMed ID: 23883294
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patient and Healthcare Professional Preferences for Characteristics of Long-Acting Injectable Antipsychotic Agents for the Treatment of Schizophrenia.
    Robinson DG; Suett M; Wilhelm A; Chaijale N; Franzenburg KR; Gandhi S; Cloud B; Mychaskiw M
    Adv Ther; 2023 May; 40(5):2249-2264. PubMed ID: 36905498
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patient preferences for chronic lymphocytic leukemia treatments: a discrete-choice experiment.
    Ravelo A; Myers K; Brumble R; Bussberg C; Koffman B; Manzoor BS; Biondo JML; Mansfield C
    Future Oncol; 2024; 20(28):2059-2070. PubMed ID: 38861284
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patient preferences and predicted relative uptake for targeted therapies in metastatic colorectal cancer: a discrete choice experiment.
    Wong XY; Lim AQJ; Shen Q; Chia JWK; Chew MH; Tan WS; Wee HL
    Curr Med Res Opin; 2020 Oct; 36(10):1677-1686. PubMed ID: 32609014
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patient Preferences for Bariatric Surgery: Findings From a Survey Using Discrete Choice Experiment Methodology.
    Rozier MD; Ghaferi AA; Rose A; Simon NJ; Birkmeyer N; Prosser LA
    JAMA Surg; 2019 Jan; 154(1):e184375. PubMed ID: 30484820
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Line of therapy and patient preferences regarding lung cancer treatment: a discrete-choice experiment.
    Janse S; Janssen E; Huwig T; Basu Roy U; Ferris A; Presley CJ; Bridges JFP
    Curr Med Res Opin; 2021 Apr; 37(4):643-653. PubMed ID: 33571024
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patient preference for a long-acting recombinant FSH product in ovarian hyperstimulation in IVF: a discrete choice experiment.
    van den Wijngaard L; Rodijk IC; van der Veen F; Gooskens-van Erven MH; Koks CA; Verhoeve HR; Mol BW; van Wely M; Mochtar MH
    Hum Reprod; 2015 Feb; 30(2):331-7. PubMed ID: 25432926
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.